Natural Cycles Gets FDA Clearance for AI Fertility Algorithm

Jul 27, 2026
Natural Cycles has received its sixth FDA clearance for its next generation AI powered NC° Fertility Algorithm. The update uses statistical modeling and machine learning to adapt fertility predictions to individual cycle patterns.
Natural Cycles Gets FDA Clearance for AI Fertility Algorithm

Natural Cycles has received its sixth FDA clearance for its next generation AI powered NC° Fertility Algorithm, the company announced in a press release.

The updated algorithm combines statistical modeling with machine learning trained on tens of millions of fertility data points. It is designed to adapt to individual cycle patterns and provide more individualized fertility predictions.

The company said evidence submitted to the FDA showed the algorithm maintained its established safety and effectiveness rates. Natural Cycles also said the update gives many users more Green Days, when the app confirms pregnancy protection is not needed.

We hope you enjoyed this article

Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.

Also, consider following us on social media:

Free newsletter

Life AI Weekly

Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.

Industry analysis

2025 Global Business Services Agenda: Gen AI Takes Center Stage

The Hackett Group

This industry analysis by The Hackett Group explores the transformative impact of generative artificial intelligence (Gen AI) on global business services (GBS) in 2025. The study highlights the shift from exploration to acceleration of Gen AI initiatives, with 89% of executives advancing these projects to improve customer satisfaction, innovate products, and reduce costs. The report also discusses the challenges and strategies for successful Gen AI adoption, emphasizing the need for a technology-enabled operating model and the importance of reskilling the workforce.

Read more
Free, six days a week

Daily AI Brief: the AI news that matters, in your inbox.